Akubue P I, Bagchi D, Ihm W J, Stohs S J
School of Pharmacy and Allied Health Professions, Creighton University, Omaha, NE 68178.
Arch Toxicol. 1994;68(5):338-41. doi: 10.1007/s002040050079.
A high pressure liquid chromatographic system (HPLC) has recently been developed for the simultaneous detection of malondialdehyde (MDA), formaldehyde (FA), acetaldehyde (ACT) and acetone (ACON). We have examined the urinary excretion of these four lipid metabolites in the urine of rats following the acute oral administration of MDA (158 mg/kg body weight). During the first 12 h, increases in the urinary excretion of MDA and ACT of approximately 192- and 70-fold, respectively, were observed. The urinary excretion of both MDA and ACT decreased thereafter. An increase in FA excretion was observed only 12-24 h after MDA administration. A significant decrease in ACON relative to control values was observed 12-48 h after MDA treatment. Two new peaks were present in the HPLC chromatograms of urine samples 0-24 h after MDA administration. Both peaks were shown to be due to methyl ethyl ketone (MEK) which appears to be formed as a result of MDA metabolism. The results demonstrate that orally administered MDA is rapidly excreted in the urine, and alters the metabolism and excretion of other lipid metabolites.
最近开发了一种高压液相色谱系统(HPLC),用于同时检测丙二醛(MDA)、甲醛(FA)、乙醛(ACT)和丙酮(ACON)。我们研究了大鼠急性口服MDA(158mg/kg体重)后尿液中这四种脂质代谢物的排泄情况。在最初的12小时内,观察到MDA和ACT的尿排泄量分别增加了约192倍和70倍。此后,MDA和ACT的尿排泄量均下降。仅在MDA给药后12 - 24小时观察到FA排泄增加。在MDA治疗后12 - 48小时观察到ACON相对于对照值显著下降。在MDA给药后0 - 24小时的尿液样本HPLC色谱图中出现了两个新峰。两个峰均显示是由于甲基乙基酮(MEK)所致,MEK似乎是MDA代谢的产物。结果表明,口服的MDA在尿液中迅速排泄,并改变了其他脂质代谢物的代谢和排泄。